SCHEMBL5078629

SCHEMBL5078629

Fc1ccc(C2CCNCC2COc2ccc3ccccc3c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK2 P25098 4/20 0.71
SLC6A4 P31645 5/20 0.68
CYP3A4 P08684 4/20 0.68
SLC6A2 P23975 3/20 0.68
TP53 P04637 2/20 0.68
CYP1A2 P05177 2/20 0.68
CYP2D6 P10635 2/20 0.68
SLC6A3 Q01959 2/20 0.68
KCNH2 Q12809 2/20 0.68
SCN5A Q14524 2/20 0.68
ALDH1A1 P00352 1/20 0.68
CYP2C9 P11712 1/20 0.68
HSD17B10 Q99714 1/20 0.68
NPC1 O15118 1/20 0.68
CACNA1F O60840 1/20 0.68
MPO P05164 1/20 0.68
ADRB2 P07550 1/20 0.68
CHRM2 P08172 1/20 0.68
CHRM4 P08173 1/20 0.68
ABCB1 P08183 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27513683 0.88 GRK2 (0.64) GRK2SLC6A4CYP3A4SLC6A2TP53
Hydrochloric Acid SCHEMBL10840525 0.86 GRK2 (0.78) GRK2SLC6A4CYP3A4SLC6A2TP53
Hydrochloric Acid SCHEMBL10840937 0.85 GRK2 (0.69) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL14607952 0.84 GRK2 (0.98) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL2739113 0.84 GRK2 (0.98) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL12086564 0.84 GRK2 (0.98) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL8266168 0.84 GRK2 (0.98) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL20336659 0.83 GRK2 (0.63) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL9397480 0.83 GRK2 (0.66) GRK2SLC6A4CYP3A4SLC6A2TP53
SCHEMBL1153008 0.82 GRK2 (0.68) GRK2SLC6A4CYP3A4SLC6A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed
EP-0266574-B1 Piperidine compounds and their preparation and use NOVO NORDISK AS (DK) 1994-01-05 EP disclosed
US-5019582-A Preventing Calcium Overload In Brain Cells NOVO NORDISK A/S (DK) 1991-05-28 US disclosed
US-4985446-A CALCIUM OVERLOAD BLOCKERS IN BRAIN CELLS A/S FERROSAN (DK) 1991-01-15 US disclosed
US-4877799-A Method of treating calcium overload in brain cells of mammals A/S FERROSAN (DK) 1989-10-31 US disclosed